Lastly, in vivo silencing of Tgm2 in CD11b + myeloid cell populations resulted in augmented pro-inflammatory responses at both the AT and systemic levels, ultimately causing increased obesity and IR. The gene discussed is TGM2; the disease is obesity due to melanocortin 4 receptor deficiency.